NOTE

🌱 created from: role_of_induction_chemotherapy-of-hnscc

tax_323

TPF

As compared with the standard regimen of cisplatin and fluorouracil, induction chemotherapy with the addition of docetaxel significantly improved progression-free and overall survival in patients with unresectable squamous-cell carcinoma of the head and neck. (ClinicalTrials.gov number, NCT00003888.)

1.Vermorken JB. Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. The New England Journal of Medicine. Published October 25, 2007. Accessed September 28, 2024. https://www-nejm-org.erm.kfsyscc.org:8443/doi/full/10.1056/NEJMoa071028